Xiangyi Zheng

5.7k total citations
138 papers, 4.1k citations indexed

About

Xiangyi Zheng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiangyi Zheng has authored 138 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 46 papers in Cancer Research and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiangyi Zheng's work include MicroRNA in disease regulation (25 papers), Cancer-related molecular mechanisms research (23 papers) and RNA modifications and cancer (19 papers). Xiangyi Zheng is often cited by papers focused on MicroRNA in disease regulation (25 papers), Cancer-related molecular mechanisms research (23 papers) and RNA modifications and cancer (19 papers). Xiangyi Zheng collaborates with scholars based in China, United States and Canada. Xiangyi Zheng's co-authors include Liping Xie, Xiao Wang, Xin Xu, Jian Wu, Qiqi Mao, Yiwei Lin, Zhen Liang, Yeqing Mao, Huaqing Yan and Jiangfeng Li and has published in prestigious journals such as PLoS ONE, Journal of Cleaner Production and Scientific Reports.

In The Last Decade

Xiangyi Zheng

129 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyi Zheng China 39 2.4k 1.7k 691 492 470 138 4.1k
Liping Xie China 42 3.1k 1.3× 1.9k 1.1× 962 1.4× 507 1.0× 644 1.4× 220 5.3k
Yue Li China 33 2.5k 1.1× 1.7k 1.0× 864 1.3× 595 1.2× 578 1.2× 217 4.7k
Pei Ma China 33 3.4k 1.4× 2.4k 1.4× 640 0.9× 304 0.6× 439 0.9× 102 4.7k
Bing Liu China 27 1.7k 0.7× 1.0k 0.6× 292 0.4× 323 0.7× 409 0.9× 91 3.9k
Mu‐Kuan Chen Taiwan 36 1.9k 0.8× 855 0.5× 396 0.6× 631 1.3× 778 1.7× 169 4.0k
Sheng Tai China 29 1.7k 0.7× 1.0k 0.6× 528 0.8× 459 0.9× 478 1.0× 110 3.6k
Jie Lin United States 41 3.2k 1.3× 1.2k 0.7× 516 0.7× 750 1.5× 636 1.4× 141 5.4k
Yasuyoshi Miyata Japan 33 1.5k 0.6× 608 0.4× 570 0.8× 542 1.1× 641 1.4× 174 3.3k
Kristin M. Nieman United States 19 1.9k 0.8× 1.7k 1.0× 396 0.6× 314 0.6× 981 2.1× 42 4.0k
Gang Song China 29 2.4k 1.0× 845 0.5× 260 0.4× 291 0.6× 755 1.6× 71 4.0k

Countries citing papers authored by Xiangyi Zheng

Since Specialization
Citations

This map shows the geographic impact of Xiangyi Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyi Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyi Zheng more than expected).

Fields of papers citing papers by Xiangyi Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyi Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyi Zheng. The network helps show where Xiangyi Zheng may publish in the future.

Co-authorship network of co-authors of Xiangyi Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyi Zheng. A scholar is included among the top collaborators of Xiangyi Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyi Zheng. Xiangyi Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiaming, Haiyun Xie, Zixiang Liu, et al.. (2025). KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathway. Cell Reports. 44(5). 115595–115595.
2.
Wu, Yuqing, Yufan Ying, Fenghao Zhang, et al.. (2024). NSUN2-mediated R-loop stabilization as a key driver of bladder cancer progression and cisplatin sensitivity. Cancer Letters. 611. 217416–217416. 4 indexed citations
3.
Wu, Jian, et al.. (2024). Population pharmacokinetics of intravenous daptomycin in critically ill patients: implications for selection of dosage regimens. Frontiers in Pharmacology. 15. 1378872–1378872. 1 indexed citations
4.
Wu, Yuqing, Lin Shen, Hong Chen, & Xiangyi Zheng. (2024). Cross-regulation of RNA methylation modifications and R-loops: from molecular mechanisms to clinical implications. Cellular and Molecular Life Sciences. 82(1). 1–1. 3 indexed citations
5.
Zheng, Xiangyi, et al.. (2023). The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer. Cancers. 15(4). 1007–1007. 9 indexed citations
6.
He, Liujia, Yufan Ying, Haiyun Xie, et al.. (2021). MicroRNA‐501‐3p inhibits the proliferation of kidney cancer cells by targeting WTAP. Cancer Medicine. 10(20). 7222–7232. 24 indexed citations
7.
Xie, Haiyun, Jiangfeng Li, Yufan Ying, et al.. (2020). METTL3/YTHDF2 m 6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer. Journal of Cellular and Molecular Medicine. 24(7). 4092–4104. 114 indexed citations
8.
Yan, Huaqing, Yufan Ying, Haiyun Xie, et al.. (2018). Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis. Cancer Management and Research. Volume 10. 3781–3791. 27 indexed citations
9.
Yan, Huaqing, Haiyun Xie, Yufan Ying, et al.. (2018). Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis. Cancer Management and Research. Volume 10. 1627–1638. 26 indexed citations
10.
Yan, Huaqing, Jiangfeng Li, Yufan Ying, et al.. (2018). MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway. Cell Cycle. 17(24). 2790–2801. 22 indexed citations
11.
Xie, Liping, et al.. (2015). Artificial neural network analysis on computerized transrectal ultrasound in early detection of prostate cancer. Zhonghua miniao waike zazhi. 36(11). 822–825. 2 indexed citations
12.
Wu, Jian, Alin Ji, Bo Xie, et al.. (2015). Is magnetic resonance/ultrasound fusion prostate biopsy better than systematic prostate biopsy? an updated meta- and trial sequential analysis. Oncotarget. 6(41). 43571–43580. 16 indexed citations
13.
Xie, Liping & Xiangyi Zheng. (2014). Efficacy of posterior tibial nerve stimulation in treating the female patients with overactive bladder. Zhonghua miniao waike zazhi. 35(9). 695–699. 1 indexed citations
14.
Xu, Xin, Jian Wu, Yeqing Mao, et al.. (2013). Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies. PLoS ONE. 8(3). e58079–e58079. 41 indexed citations
15.
Shen, Jie, Yanqi Xie, Yiwei Lin, et al.. (2013). Promoter-targeted double-stranded small RNAs activate PAWR gene expression in human cancer cells. The International Journal of Biochemistry & Cell Biology. 45(7). 1338–1346. 28 indexed citations
16.
Li, Shiqi, Xianglai Xu, Xin Xu, et al.. (2013). MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. Biochemical and Biophysical Research Communications. 441(4). 976–981. 58 indexed citations
17.
Bai, Yu, Qiqi Mao, Jie Qin, et al.. (2009). Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Science. 101(2). 488–493. 162 indexed citations
18.
Zheng, Xiangyi. (2009). Expression of COX-2 in Cystitis Glandularis and Its Implication to Relapse. Zhongguo quanke yixue. 1 indexed citations
19.
Qin, Qi, Xiangyi Zheng, Yuyong Wang, et al.. (2009). Langerhans’ cell density and degree of keratinization in foreskins of Chinese preschool boys and adults. International Urology and Nephrology. 41(4). 747–753. 23 indexed citations
20.
Zheng, Xiangyi, Liping Xie, Jie Qin, et al.. (2007). Effects of wortmannin on phosphorylation of PDK1, GSK3-β, PTEN and expression of Skp2 mRNA after ischemia/reperfusion injury in the mouse kidney. International Urology and Nephrology. 40(1). 185–192. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026